In Brief for Feb. 8, 2023

In Brief for July 26, 2023

IASLC Names New Chief Science Officer

Patient Advocate Ivy B. Elkins Leaves Lasting Legacy

Laura Greco of “Die, Cancer, Die!” Fame will be Remembered for her Passionate Patient Advocacy

Nivolumab Boosted Survival in Relapsed Mesothelioma

KEYNOTE-598: Dual PD-1 and CTLA-4 Checkpoint Blockade Confers No Therapeutic Benefit Beyond PD-1 Blockade Alone in PD-L1–Positive NSCLC

LCMC3 Findings Indicate Neoadjuvant Atezolizumab Safe, Efficacious in Resectable Stage IB-IIIB NSCLC

Genetically Tailored Treatment Approach Did Not Improve Survival in Stage II-III NSCLC